13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$496.55B
−15% on the quarter before
Positions
2,056
177 new · 222 sold out
Top 10
18.0%
of the value
Est. gain
−$73.59B
on stocks held all quarter
Est. return
−13.7%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tjx Cos Inc New~$984.4MAdded · 0.9% → 1.2%+17,625,647 shares
- Nike Inc~$865.8MAdded · 0.4% → 0.5%+8,471,839 shares
- Starbucks Corp~$826.0MAdded · 0.2% → 0.4%+10,813,118 shares
- Qualcomm~$792.7MAdded · 0.1% → 0.2%+6,205,741 shares
- Nxp Semiconductors N V~$785.6MAdded · 0.1% → 0.2%+5,306,828 shares
- Microsoft~$779.3MAdded · 3.2% → 3.3%+3,034,209 shares
- Coterra Energy Inc~$641.3MAdded · 0.2% → 0.3%+24,866,261 shares
- Meta~$588.2MAdded · 0.7% → 0.7%+3,647,626 shares
- Moderna Inc~$581.1MAdded · 0.0% → 0.1%+4,067,828 shares
- Morgan Stanley~$505.8MAdded · 0.6% → 0.7%+6,649,370 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bk Of America Corp~$2.04BCut · 0.6% → 0.1%−65,662,892 shares
- Eli Lilly~$1.23BCut · 1.3% → 1.5%−3,786,064 shares
- Pioneer Nat Res Co~$850.8MCut · 0.4% → 0.3%−3,813,911 shares
- Procter And Gamble Co~$819.1MCut · 1.2% → 1.2%−5,696,730 shares
- Raytheon Technologies Corp~$802.6MCut · 0.9% → 0.9%−8,350,693 shares
- Unitedhealth Group Inc~$748.3MCut · 2.4% → 2.7%−1,456,970 shares
- Coca Cola Co~$742.6MCut · 0.9% → 0.9%−11,804,940 shares
- Alphabet~$706.2MCut · 1.9% → 1.6%−324,048 shares
- American Express Co~$675.8MCut · 0.9% → 0.7%−4,875,037 shares
- S&P Global Inc~$664.6MCut · 0.6% → 0.4%−1,971,609 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +5.0% · price −16.7% | 3.3% | $16.46B | −$3.14B | ||||||||
| Unitedhealth Group IncCOM · shares −5.2% · price +0.7% | 2.7% | $13.63B | +$97.1M | ||||||||
| Pfizer IncCOM · shares +1.2% · price +1.3% | 2.3% | $11.49B | +$143.0M | ||||||||
| AppleCOM · shares −1.2% · price −21.7% | 1.8% | $9.07B | −$2.51B | ||||||||
| AlphabetCAP STK CL A · shares −8.3% · price −21.6% | 1.6% | $7.79B | −$2.15B | ||||||||
| Eli LillyCOM · shares −14% · price +13.2% | 1.5% | $7.60B | +$887.3M | ||||||||
| AmazonCOM · shares −0.8% · price −41.4% | 1.3% | $6.26B | −$4.42B | ||||||||
| Procter And Gamble CoCOM · shares −12% · price −5.9% | 1.2% | $5.95B | −$373.0M | ||||||||
| Tjx Cos Inc NewCOM · shares +21% · price −7.8% | 1.2% | $5.73B | −$401.7M | ||||||||
| Johnson & JohnsonCOM · shares −9.9% · price +0.2% | 1.1% | $5.24B | +$8.3M | ||||||||
| Texas InstrumentsCOM · shares +8.3% · price −16.3% | 1.1% | $5.23B | −$937.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares +2.6% · price −17.4% | 1.0% | $4.99B | −$1.02B | ||||||||
| MastercardCL A · shares −0.6% · price −11.7% | 0.99% | $4.92B | −$653.0M | ||||||||
| Mcdonalds CorpCOM · shares −4.9% · price −0.2% | 0.98% | $4.88B | −$7.9M | ||||||||
| Danaher CorporationCOM · shares +4.9% · price −13.6% | 0.97% | $4.81B | −$719.6M | ||||||||
| Schwab Charles CorpCOM · shares −2.3% · price −25.1% | 0.96% | $4.78B | −$1.60B | ||||||||
| Anthem IncCOM · shares −2.8% · price −1.8% | 0.96% | $4.75B | −$85.1M | ||||||||
| Chubb LimitedCOM · shares −12% · price −8.1% | 0.95% | $4.71B | −$414.9M | ||||||||
| Visa Inc.COM CL A · shares +5.1% · price −11.2% | 0.93% | $4.60B | −$552.9M | ||||||||
| Raytheon Technologies CorpCOM · shares −15% · price −3.0% | 0.90% | $4.49B | −$138.2M | ||||||||
| Humana IncCOM · shares +7.1% · price +7.6% | 0.89% | $4.40B | +$288.7M | ||||||||
| Coca Cola CoCOM · shares −15% · price +1.5% | 0.87% | $4.33B | +$62.7M | ||||||||
| Exelon CorporationCOM · shares −3.1% · price −4.8% | 0.82% | $4.09B | −$208.6M | ||||||||
| Baxter Intl IncCOM · shares +11% · price −17.2% | 0.80% | $3.98B | −$739.6M | ||||||||
| Northrop Grumman CorpCOM · shares −8.1% · price +7.0% | 0.77% | $3.82B | +$250.0M | ||||||||
| Total · 2,056 positions | 100% | $496.55B | −$73.59B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 1,794 stocks held throughout, down $73.59B (−13.7%).
- Eli Lilly+$887.3M+13%
- Merck & Co Inc+$371.4M+11%
- Humana Inc+$288.7M+8%
- Seagen Inc+$287.0M+23%
- Northrop Grumman Corp+$250.0M+7%
- Schwab Charles Corp−$1.60B−25%
- Alphabet−$2.15B−22%
- Apple−$2.51B−22%
- Microsoft−$3.14B−17%
- Amazon18:1 split−$4.42B−41%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |